Related Experiment Video
Updated: Jan 9, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
Successful Management of Relapsing Primary Focal Segmental Glomerulosclerosis With Tacrolimus and Mycophenolate
Frank Lee1, Albert Yeam1, Marrey Ruby Quizon2
1School of Medicine, University of California-Irvine, Irvine, California, USA.
None:
Focal segmental glomerulosclerosis (FSGS) is a leading cause of nephrotic syndrome, often resistant to corticosteroid therapy. We report a 75-year-old female with relapsing primary FSGS successfully treated with a dual regimen of tacrolimus and mycophenolate mofetil (MMF) without steroids or cyclophosphamide. Following three years of combination therapy, with concurrent renin-angiotensin system and sodium-glucose cotransporter-2 inhibition, the patient achieved sustained remission with proteinuria < 500 mg/day, without complications. This case underscores the potential of tacrolimus and MMF as a steroid-sparing strategy in managing refractory FSGS. Further research is needed to validate this approach in larger patient populations.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Therapeutic Drug Monitoring: Affecting Factors
Nephrotic Syndrome II : Assessment and Medical Management
Kidney Transplant III: Nursing Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Chronic Kidney Disease III: Interprofessional Care

